CD3E, Human (Otelixizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD3E, Human (Otelixizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD3E, Human (Otelixizumab biosimilar)
CloneOtelixizumab
Host SpeciesRecombinant Rat
Reactive Specieshuman
IsotypeIgG1 lambda
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsFCM, IP, ELISA, Neut, FuncS, IF, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD3E Recombinant Antibody (Otelixizumab). Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.
Immunogenn/a
Other NamesAnti-CD3E Recombinant Antibody, Research Grade Otelixizumab, Anti-Human CD3E Recombinant Antibody(Otelixizumab), ChAglyCD, TRX4, otelixizumab, 881191-44-2, TRX4, Antibody Drug Analogues, Monoclonal Antibody, YR1152, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 881191-44-2
Catalog #YR1152
Priceplease inquire
Order / More InfoCD3E, Human (Otelixizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.